RedHill Biopharma Ltd.(RDHL)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

RedHill Biopharma Ltd. (RDHL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RDHL at 27.3/100 on a 32-signal composite quality model, placing it at rank #2,585 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of RDHL by reported 13-F value include Yorkville Advisors Global, GAGNON SECURITIES, CITADEL ADVISORS, based on the most recent SEC filings. RDHL trades on the Nasdaq exchange and files with the SEC under CIK 1553846. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RDHL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for RedHill Biopharma Ltd. directly from SEC EDGAR.

AI Quality Score

27.3/100

AI Rank

#2,585

RDHL key financials by period

RedHill Biopharma Ltd. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202420-F$8.0M——
FY 202320-F$6.5M——
FY 202220-F$61.8M——
FY 202120-F$85.8M——
FY 202020-F$64.4M——
FY 201920-F$6.3M——

Institutions holding RDHL

Institutional investors reporting a position in RedHill Biopharma Ltd. on SEC Form 13F.
InstitutionSharesValueReported
Yorkville Advisors Global122,131$106.7K2026-06-30
GAGNON SECURITIES88,405$74.7K2026-06-30
CITADEL ADVISORS65,321$55.2K2026-06-30
RHUMBLINE ADVISERS13,755$11.6K2026-06-30
Lido Advisors11,009$9.3K2026-06-30
GAMMA Investing6,957$5.9K2026-06-30
CITIGROUP4,378$3.7K2026-06-30
Federation des caisses Desjardins du Quebec3,388$2.9K2026-06-30
UBS Group AG100$85.002026-06-30
SBI Securities , Ltd.15$13.002026-06-30
SEC EDGAR: CIK 1553846 →
RDHL

RedHill Biopharma Ltd.

RDHL
NasdaqLarge CapHealthcare

13F Pro Quality Score

27.3/100

Rank #2,585 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$270.0K total
Yorkville Advisors Global, LP
$106.7K-65.2%
GAGNON SECURITIES LLC
$74.7K0.0%
CITADEL ADVISORS LLC
$55.2K+216.0%
RHUMBLINE ADVISERS
$11.6K+168.9%
Lido Advisors, LLC
$9.3KNew
GAMMA Investing LLC
$5.9K+4.1%
CITIGROUP INC
$3.7KNew
Federation des caisses Desjardins du Quebec
$2.9K0.0%
UBS Group AG
$85-87.9%
SBI Securities Co., Ltd.
$13+275.0%

Financial Trends

Revenue & Net Income

Loading ratio trend…